Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sutent in Unresectable Hepatocellular Carcinoma
NCT00514228Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Jul 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in hepatocellular carcinoma (HCC), sponsored by Swiss Group for Clinical Cancer Research. Started Jul 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00514228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514228.